Arrowstreet Capital’s Arcellx ACLX Stock Holding History

Arrowstreet Capital’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,500	Closed	-$243K	–	1487
2024 Q1	$243K	Buy	+3,500	New	+$222K	﹤0.01%	1553

Other funds holding ACLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital's ACLX Position: Q2 2024 in Review

Arrowstreet Capital sold out of Arcellx (ACLX) in Q2 2024, closing a stake of 3,500 shares — an estimated $243K sold.

Arrowstreet Capital first reported a position in ACLX in Q1 2024 and held it in 1 quarter. The position peaked at $243K in Q1 2024. 167 funds tracked by Wall St. Rank hold ACLX as of Q2 2024.

Arrowstreet Capital reported no remaining Arcellx position as of Q2 2024 after selling out during the quarter.
Arrowstreet Capital sold 3,500 Arcellx shares in Q2 2024, an estimated $243K.
Arrowstreet Capital first reported a position in Arcellx in Q1 2024 and held it in 1 quarter.
Arrowstreet Capital's Arcellx position peaked at $243K in Q1 2024.
167 funds tracked by Wall St. Rank held Arcellx as of Q2 2024.

Based on Arrowstreet Capital's 13F filing for Q2 2024, filed 14 Aug 2024.